Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients (PRADA)

This study has been completed.
Sponsor:
Information provided by:
Radboud University
ClinicalTrials.gov Identifier:
NCT00943540
First received: July 21, 2009
Last updated: January 7, 2011
Last verified: January 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
No publications provided by Radboud University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):